Gelesis Holdings, Inc. ( GLSHQ) - Key Metrics
GLSHQ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q2 | $0.02 | -$0.10 | $0.01 | $0.01 |
| 2023Q1 | $0.02 | -$0.07 | -$0.12 | -$0.12 |
| 2022Q4 | $0.04 | -$0.33 | -$0.22 | -$0.23 |
| 2022Q3 | $0.09 | -$0.20 | -$0.30 | -$0.34 |
| 2022Q2 | $0.12 | -$0.17 | -$0.06 | -$0.11 |
GLSHQ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q2 | 0% | -0.09 |
| 2023Q1 | 0% | -0.57 |
| 2022Q4 | 0% | -0.22 |
| 2022Q3 | 0% | -1.35 |
| 2022Q2 | 0% | -2.28 |
GLSHQ Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2023Q2 | 22.69% | 0% |
| 2023Q1 | -74.63% | 0% |
| 2022Q4 | -79.73% | 0% |
| 2022Q3 | -31.92% | 0% |
| 2022Q2 | -6.85% | 0% |
GLSHQ
Price: $0
52 week price:
Earnings Per Share: -0.70 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7334